Home

Improving Clinical Outcomes Following Subarachnoid Hemmorhage Using CT Perfusion

Pina Christine Sanelli
Radiologyweill Medical College Of Cornell Univ

Grant 1K23NS058387-01A2 from National Institute Of Neurological Disorders And Stroke, IRG: NST

Abstract: Cerebral vasospasm is not well understood leading to indeterminate diagnosis and delayed treatment following aneurysmal subarachnoid hemorrhage (A-SAH). There is poor clinical outcome associated with vasospasm due to permanent neurologic deficit, stroke and death. Stroke has been detected in up to 81% of A-SAH patients, affecting 21,000-33,000 persons each year in the United States. As many as 46% have long-term cognitive impairment, affecting functional status and quality of life. Thereby, this disorder is also associated with a substantial burden on public health care costs and resources, mostly related to hospitalization, long-term care and indirect economic costs of disability. Our long-term goal is to improve clinical outcomes of patients following A-SAH by implementing CT perfusion (CTP) as a means to 1) provide earlier and more accurate diagnosis of vasospasm, and 2) guide effective treatment strategies. Our hypothesis for this research proposal is that appropriate use of CTP will improve the clinical outcomes of A-SAH patients by providing earlier and more accurate diagnosis of vasospasm. Using a prospective cohort study design, A-SAH patients will be monitored according to their symptoms, transcranial Doppler ultrasound (TCD), CT angiography (CTA), CTP and digital subtraction angiograpghy (DSA) exams. The primary objective is to determine the performance of CTP as a diagnostic tool in the evaluation of vasospasm, by these specific aims 1) To determine the sensitivity, specificity, positive and negative predictive values of CTP, 2) to compare sensitivity and specificity of CTP with symptoms, TCD, CTA and DSA, and 3) to identify the combination of modalities that provides the earliest diagnosis. The secondary objective is to evaluate the impact of CTP for diagnosis of vasospasm, with these specific aims 4) To assess the effect of CTP on diagnostic certainty and management decision making, 5) to determine the effect of CTP on clinical outcomes, and 6) to perform cost-effectiveness analysis. A strong mentoring program at my institution with a well-structure educational curriculum at the Harvard School of Public Health and Weill Graduate School of Medical Sciences of Cornell University will greatly enhance my clinical research skills and build on my prior research experience to develop into an independent clinical investigator in this field

Project start date: 2008-08-01

Project end date: 2013-07-31


Sponsored Links Lab Supply Mall http://www.labsupplymall.com

New Invitrogen UltraPure Agarose 500g
UltraPure Agarose resolves DNA and RNA fragments from 100 bp to >30 kb. $432, $350
Qiagen Ni-NTA Agarose beads 25 ml Cat # 30210
For purification of 6xHis-tagged proteins by gravity-flow chromatography. $225, $180
Qiagen RNeasy Mini Kit (50), Cat # 74104
For purification of up to 100 ug total RNA from animal cells or tissues, yeast, or bacteria. $219, $170
Qiagen QIAEX II Gel Extraction Kit (150), Cat # 20021
For batch purification of DNA fragments (40 bp to 50 kb) from agarose gels and from solutions. $137, $105
Qiagen Plasmid Maxi Kit (25), Cat # 12163
For purification of up to 500 ug transfection grade plasmid or cosmid DNA. $454, $395
Invitrogen Human Cot-1 DNA Cat# 15279-011
Block non-specific hybridization in microarray screening. $155, $120
Invitrogen Life Technology Gibo Lipofectamine 2000, 1.5 ml, Cat 11668-019
Unsurpassed Results for DNA and siRNA Transfections. $399, $350
GenJetTM In Vitro DNA Transfection Reagent
A more affordable alternative to Invitrogen's lipofetacmine 2000. $178, $139
GR Safe Nucleic Acid Stain
Excellent Alternative to Ethidium Bromide: Safety, Sensitivity, Stability. $78, $58
QIAGEN Plasmid Maxi Kit (10), Cat # 12162
For purification of up to 500 ug transfection grade plasmid or cosmid DNA. $192, $150


Grants awarded to Pina Christine Sanelli

Improving Clinical Outcomes Following Subarachnoid Hemmorhage Using CT Perfusion

Pina Christine Sanelli
Radiologyweill Medical College Of Cornell Univ

Grant 1K23NS058387-01A2 from National Institute Of Neurological Disorders And Stroke, IRG: NST

Abstract: Cerebral vasospasm is not well understood leading to indeterminate diagnosis and delayed treatment following aneurysmal subarachnoid hemorrhage (A-SAH). There is poor clinical outcome associated with vasospasm due to permanent neurologic deficit, stroke and death. Stroke has been detected in up to 81% of A-SAH patients, affecting 21,000-33,000 persons each year in the United States. As many as 46% have long-term cognitive impairment, affecting functional status and quality of life. Thereby, this disorder is also associated with a substantial burden on public health care costs and resources, mostly related to hospitalization, long-term care and indirect economic costs of disability. Our long-term goal is to improve clinical outcomes of patients following A-SAH by implementing CT perfusion (CTP) as a means to 1) provide earlier and more accurate diagnosis of vasospasm, and 2) guide effective treatment strategies. Our hypothesis for this research proposal is that appropriate use of CTP will improve the clinical outcomes of A-SAH patients by providing earlier and more accurate diagnosis of vasospasm. Using a prospective cohort study design, A-SAH patients will be monitored according to their symptoms, transcranial Doppler ultrasound (TCD), CT angiography (CTA), CTP and digital subtraction angiograpghy (DSA) exams. The primary objective is to determine the performance of CTP as a diagnostic tool in the evaluation of vasospasm, by these specific aims 1) To determine the sensitivity, specificity, positive and negative predictive values of CTP, 2) to compare sensitivity and specificity of CTP with symptoms, TCD, CTA and DSA, and 3) to identify the combination of modalities that provides the earliest diagnosis. The secondary objective is to evaluate the impact of CTP for diagnosis of vasospasm, with these specific aims 4) To assess the effect of CTP on diagnostic certainty and management decision making, 5) to determine the effect of CTP on clinical outcomes, and 6) to perform cost-effectiveness analysis. A strong mentoring program at my institution with a well-structure educational curriculum at the Harvard School of Public Health and Weill Graduate School of Medical Sciences of Cornell University will greatly enhance my clinical research skills and build on my prior research experience to develop into an independent clinical investigator in this field

Project start date: 2008-08-01

Project end date: 2013-07-31



Related Publications